These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34805945)

  • 1. A new choice of stent for transjugular intrahepatic portosystemic shunt creation: Viabahn ePTFE covered stent/bare metal stent combination.
    Liu J; Meng J; Zhou C; Shi Q; Yang C; Ma J; Chen M; Xiong B
    J Interv Med; 2021 Feb; 4(1):32-38. PubMed ID: 34805945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.
    Zhu P; Dong S; Sun P; Belgaumkar AP; Sun Y; Cheng X; Zheng Q; Li T
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012358. PubMed ID: 37531575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison study of Doppler ultrasound surveillance of expanded polytetrafluoroethylene-covered stent versus bare stent in transjugular intrahepatic portosystemic shunt.
    Huang Q; Wu X; Fan X; Cao J; Han J; Xu L; Li N
    J Clin Ultrasound; 2010 Sep; 38(7):353-60. PubMed ID: 20533444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Covered Self-Expandable Viatorr CX Stent with the Covered Balloon-Expandable BeGraft Peripheral Stent for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation: a Single-Centre Retrospective Study in Patients with Variceal Bleeding.
    Schultheiss M; Bettinger D; Sturm L; Schmidt A; Backhus J; Waidmann O; Radecke K; Grandt D; Thimme R; Rössle M
    Cardiovasc Intervent Radiol; 2022 May; 45(5):542-549. PubMed ID: 35020042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of curative efficacy of transjugular intrahepatic portosystemic shunt using viabahn stent in the treatment of Budd-Chiari syndrome with extensive hepatic vein occlusion].
    Zhao C; Zhang QQ; Xu H; Wei N; Cui YF; Liu HT; Wang WL; Xiao JC; Zu MH
    Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):972-976. PubMed ID: 34814391
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
    Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
    [No Abstract]   [Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.
    Hausegger KA; Karnel F; Georgieva B; Tauss J; Portugaller H; Deutschmann H; Berghold A
    J Vasc Interv Radiol; 2004 Mar; 15(3):239-48. PubMed ID: 15028808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of specialized stent versus generic stent and bare stent combination for transjugular intrahepatic portosystemic shunt creation.
    Bai Y; Liu J; Wang C; Yao W; Ju S; Wang Y; Zhou C; Dong X; Zheng C
    Sci Rep; 2024 Jun; 14(1):14439. PubMed ID: 38910214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis.
    Wang CM; Li X; Fu J; Luan JY; Li TR; Zhao J; Dong GX
    Chin Med J (Engl); 2016 Jun; 129(11):1261-7. PubMed ID: 27231160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
    Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
    Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt (Tips) Creation Using Fluency Versus Viatorr Stent-Grafts: A Single-Centre Retrospective Study.
    Wu HM; Huang SQ; Wan YM; Li YH; Xu Y
    Cardiovasc Intervent Radiol; 2022 May; 45(5):552-562. PubMed ID: 35274174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of puncturing different portal vein branch during transjugular intrahepatic portosystemic shunt with 8 mm covered stent: a propensity-score analysis.
    Zhou Y; Ma J; Ju S; Zhang Z; Zhang W; Yang M; Zhou X; Yan Z; Luo J
    Eur J Gastroenterol Hepatol; 2021 Aug; 33(8):1110-1116. PubMed ID: 33741800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
    Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
    Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic shunt using the FLUENCY expanded polytetrafluoroethylene-covered stent.
    Wu Q; Jiang J; He Y; Jiang T; Zhou S
    Exp Ther Med; 2013 Jan; 5(1):263-266. PubMed ID: 23251280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
    Wang Q; Lv Y; Bai M; Wang Z; Liu H; He C; Niu J; Guo W; Luo B; Yin Z; Bai W; Chen H; Wang E; Xia D; Li X; Yuan J; Han N; Cai H; Li T; Xie H; Xia J; Wang J; Zhang H; Wu K; Fan D; Han G
    J Hepatol; 2017 Sep; 67(3):508-516. PubMed ID: 28506905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.
    Charon JP; Alaeddin FH; Pimpalwar SA; Fay DM; Olliff SP; Jackson RW; Edwards RD; Robertson IR; Rose JD; Moss JG
    J Vasc Interv Radiol; 2004 Nov; 15(11):1219-30. PubMed ID: 15525740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of covered stent length in portal and hepatic veins on long-term clinical efficacy of transjugular intrahepatic portosystemic shunt].
    Hu P; Chen SL; Lin ZP; Zhao JB; Chen Y; He XF; Zeng QL; Li YH
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1444-1448. PubMed ID: 27777214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular Intrahepatic Portosystemic Shunt:The Impact of Portal Venous Pressure Declines on Shunt Patency and Clinical Efficacy.
    Wan YM; Li YH; Xu ZY; Wu HM; Wu XN; Xu Y; Guo T
    Acad Radiol; 2019 Feb; 26(2):188-195. PubMed ID: 29934023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study.
    Wang HL; Lu WJ; Zhang YL; Nie CH; Zhou TY; Zhou GH; Zhu TY; Wang BQ; Chen SQ; Yu ZN; Jing L; Sun JH
    Front Med (Lausanne); 2021; 8():737984. PubMed ID: 34671621
    [No Abstract]   [Full Text] [Related]  

  • 20. Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist's Experience.
    Buechter M; Manka P; Gerken G; Canbay A; Blomeyer S; Wetter A; Altenbernd J; Kahraman A; Theysohn JM
    Dig Dis; 2018; 36(3):218-227. PubMed ID: 29316565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.